NM_207581.4:c.554+6T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_207581.4(DUOXA2):​c.554+6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.894 in 1,612,548 control chromosomes in the GnomAD database, including 654,719 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 49337 hom., cov: 34)
Exomes 𝑓: 0.91 ( 605382 hom. )

Consequence

DUOXA2
NM_207581.4 splice_region, intron

Scores

2
Splicing: ADA: 0.007383
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.44

Publications

11 publications found
Variant links:
Genes affected
DUOXA2 (HGNC:32698): (dual oxidase maturation factor 2) This gene encodes an endoplasmic reticulum protein that is necessary for proper cellular localization and maturation of functional dual oxidase 2. Mutations in this gene have been associated with thyroid dyshormonogenesis 5.[provided by RefSeq, Feb 2010]
DUOXA2 Gene-Disease associations (from GenCC):
  • thyroid dyshormonogenesis 5
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • familial thyroid dyshormonogenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 15-45116735-T-C is Benign according to our data. Variant chr15-45116735-T-C is described in CliVar as Benign. Clinvar id is 263305.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-45116735-T-C is described in CliVar as Benign. Clinvar id is 263305.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-45116735-T-C is described in CliVar as Benign. Clinvar id is 263305.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.916 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DUOXA2NM_207581.4 linkc.554+6T>C splice_region_variant, intron_variant Intron 4 of 5 ENST00000323030.6 NP_997464.2 Q1HG44-1
DUOXA2XM_017022180.2 linkc.605+6T>C splice_region_variant, intron_variant Intron 4 of 5 XP_016877669.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DUOXA2ENST00000323030.6 linkc.554+6T>C splice_region_variant, intron_variant Intron 4 of 5 1 NM_207581.4 ENSP00000319705.5 Q1HG44-1
DUOXA2ENST00000491993.2 linkn.*621+6T>C splice_region_variant, intron_variant Intron 4 of 5 1 ENSP00000454110.1 Q1HG44-2
DUOXA2ENST00000350243.10 linkn.840T>C non_coding_transcript_exon_variant Exon 4 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.773
AC:
117438
AN:
151976
Hom.:
49341
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.407
Gnomad AMI
AF:
0.896
Gnomad AMR
AF:
0.859
Gnomad ASJ
AF:
0.914
Gnomad EAS
AF:
0.938
Gnomad SAS
AF:
0.934
Gnomad FIN
AF:
0.915
Gnomad MID
AF:
0.861
Gnomad NFE
AF:
0.919
Gnomad OTH
AF:
0.810
GnomAD2 exomes
AF:
0.882
AC:
217490
AN:
246526
AF XY:
0.892
show subpopulations
Gnomad AFR exome
AF:
0.396
Gnomad AMR exome
AF:
0.865
Gnomad ASJ exome
AF:
0.915
Gnomad EAS exome
AF:
0.942
Gnomad FIN exome
AF:
0.924
Gnomad NFE exome
AF:
0.919
Gnomad OTH exome
AF:
0.904
GnomAD4 exome
AF:
0.907
AC:
1324103
AN:
1460454
Hom.:
605382
Cov.:
52
AF XY:
0.909
AC XY:
660477
AN XY:
726518
show subpopulations
African (AFR)
AF:
0.393
AC:
13140
AN:
33464
American (AMR)
AF:
0.862
AC:
38485
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.918
AC:
23981
AN:
26132
East Asian (EAS)
AF:
0.935
AC:
37110
AN:
39686
South Asian (SAS)
AF:
0.930
AC:
80169
AN:
86242
European-Finnish (FIN)
AF:
0.925
AC:
48490
AN:
52434
Middle Eastern (MID)
AF:
0.897
AC:
5119
AN:
5706
European-Non Finnish (NFE)
AF:
0.921
AC:
1023856
AN:
1111766
Other (OTH)
AF:
0.891
AC:
53753
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
6650
13300
19951
26601
33251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21426
42852
64278
85704
107130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.772
AC:
117463
AN:
152094
Hom.:
49337
Cov.:
34
AF XY:
0.779
AC XY:
57946
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.407
AC:
16826
AN:
41370
American (AMR)
AF:
0.859
AC:
13147
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.914
AC:
3173
AN:
3472
East Asian (EAS)
AF:
0.938
AC:
4846
AN:
5166
South Asian (SAS)
AF:
0.933
AC:
4504
AN:
4826
European-Finnish (FIN)
AF:
0.915
AC:
9698
AN:
10594
Middle Eastern (MID)
AF:
0.857
AC:
252
AN:
294
European-Non Finnish (NFE)
AF:
0.918
AC:
62492
AN:
68038
Other (OTH)
AF:
0.809
AC:
1708
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
985
1970
2955
3940
4925
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.884
Hom.:
103083
Bravo
AF:
0.752
Asia WGS
AF:
0.880
AC:
3061
AN:
3478
EpiCase
AF:
0.923
EpiControl
AF:
0.923

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Thyroglobulin synthesis defect Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
15
DANN
Benign
0.75
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0074
dbscSNV1_RF
Benign
0.034
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2576092; hg19: chr15-45408933; API